National Reye's Syndrome Foundation
Requests that FDA-mandated labeling for products containing aspirin be extended to all salicylate-containing products. "Too many cases of Reye's Syndrome have suspiciously been linked to one product in particular, [Procter & Gamble's] Pepto-Bismol, to account for it being coincidental," Chicago Chapter President Carolyn Jender maintained in a recent letter to FDA. The foundation believes that 20%-25% of Reye's Syndrome reported cases are the result of salicylate-containing products.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.